EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Nano-Drug Delivery Systems for Chronic Autoimmune Diseases: A Focus on Diabetes Mellitus, Inflammatory Bowel Disease, and Rheumatoid Arthritis

Mengqing Hu, Yimiao Zhou iD, Lin Yang, Liquan Zhou iD, Xiao Liu, Tianjin Ma, Zuowei Xiao iD

Molecules · 14.06.2026 · 31 (12) · 2094

DOI: 10.3390/molecules31122094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 14.06.2026. Verfasst von Mengqing Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Engineering and Technology Research Center for Health Products and Life Science, School of Pharmacy, Hunan University of Chinese Medicine, Chan…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Inflammatory Bowel Diseases, Diabetes Mellitus, Drug Delivery Systems. Die Arbeit nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Natural Science Foundation, State Administration of Traditional Chinese Medicine of traditional Chinese medicine monitoring statistics research subject, Modern Agricultural Technology System of Traditional Chinese Medicine in Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global prevalence of autoimmune diseases ranges from 3% to 8%, with women at a significantly higher risk than men. The core mechanisms underlying these diseases include impaired T-cell and B-cell immune tolerance, abnormal cytokine production, and aberrant activation of related signaling pathways. Conventional treatments primarily focus on suppressing immune responses, but their efficacy remains limited and they are often associated with substantial side effects. Nanomedicine leverages nanoscale materials to enable precise diagnosis and targeted therapy. Nanocarriers can penetrate biological barriers, enhance cellular uptake, and prolong circulation time in vivo, demonstrating considerable potential for drug delivery. Common nanoscale drug delivery platforms include nanoparticles, polymeric micelles, liposomes, dendrimers, mesoporous materials, hydrogels, and exosomes. Each carrier type possesses distinct characteristics in terms of drug-loading capacity, stability, responsiveness, and biocompatibility, thereby enabling targeted delivery and controlled release. This review summarizes recent advances in nano-delivery technologies for three representative chronic autoimmune diseases: diabetes mellitus (DM), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA). Nano-delivery systems can improve therapeutic outcomes by optimizing drug delivery, targeting complications, and modulating the pathological microenvironment. They enhance drug bioavailability, reduce off-target and systemic adverse effects, and provide novel strategies for the precise and efficient treatment of chronic autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidInflammatory Bowel DiseasesDiabetes MellitusDrug Delivery SystemsAutoimmune DiseasesNanoparticle Drug Delivery SystemHumansAnimalsNanoparticlesDrug CarriersNanomedicine

Stichwörter der Autor:innen

autoimmune diseasesdiabetes mellitusdrug deliveryinflammatory bowel diseasenanocarriersrheumatoid arthritis

Substanzen

Nanoparticle Drug Delivery SystemDrug Carriers

Autor:innen und Institutionen

  • Hunan Engineering and Technology Research Center for Health Products and Life Science, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
  • Xiangxing College, Hunan University of Chinese Medicine, Xiangyin Campus, Yueyang 414615, China.
  • Homologous Innovation Laboratory of Medicine and Food, Hunan University of Chinese Medicine, Changsha 410208, China.
  • Guizhou Institute of Crop Germplasm Resources, Guizhou Academy of Agricultural Sciences, Guiyang 550006, China.

ORCID-Profile: Yimiao Zhou, Liquan Zhou, Zuowei Xiao

Förderung

  • Hunan Natural Science Foundation
  • State Administration of Traditional Chinese Medicine of traditional Chinese medicine monitoring statistics research subject
  • Modern Agricultural Technology System of Traditional Chinese Medicine in Guizhou Province

Zitieren

APA

Hu, M., Zhou, Y., Yang, L., Zhou, L., Liu, X., Ma, T., & Xiao, Z. (2026). Advances in Nano-Drug Delivery Systems for Chronic Autoimmune Diseases: A Focus on Diabetes Mellitus, Inflammatory Bowel Disease, and Rheumatoid Arthritis. Molecules, 31(12), 2094. https://doi.org/10.3390/molecules31122094

Vancouver

Hu M, Zhou Y, Yang L, Zhou L, Liu X, Ma T, et al. Advances in Nano-Drug Delivery Systems for Chronic Autoimmune Diseases: A Focus on Diabetes Mellitus, Inflammatory Bowel Disease, and Rheumatoid Arthritis. Molecules. 2026;31(12):2094. doi:10.3390/molecules31122094

BibTeX
@article{Hu2026,
  author = {Hu, Mengqing and Zhou, Yimiao and Yang, Lin and Zhou, Liquan and Liu, Xiao and Ma, Tianjin and Xiao, Zuowei},
  title = {Advances in Nano-Drug Delivery Systems for Chronic Autoimmune Diseases: A Focus on Diabetes Mellitus, Inflammatory Bowel Disease, and Rheumatoid Arthritis},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {12},
  pages = {2094},
  doi = {10.3390/molecules31122094}
}
Kostenlos starten →